Angiogenesis and microvascular remodeling: A brief history and future roadmap

Microcirculation

Volumn 12, Issue 1, 2005, Pages 47-58

  Skalak, Thomas C ^a  

^a University of Virginia   (United States)

Author keywords

Angiogenesis; Arterialization; Arteriogenesis; Cell lineage; Microvascular remodeling; Systems biology

Indexed keywords

ANGIOPOIETIN 1; ANGIOTENSIN; ANGIOTENSIN I; FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PEPTIDE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; BIOASSAY; BLOOD VESSEL PERMEABILITY; CELL BASED GENE THERAPY; CELL LINEAGE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; EMBRYO DEVELOPMENT; EX VIVO STUDY; EXTRACELLULAR MATRIX; HEMODYNAMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; MEDICAL RESEARCH; MEDICAL SOCIETY; MICROCIRCULATION; MICROENVIRONMENT; MICROVASCULATURE; MOLECULAR GENETICS; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PLEIOTROPY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVASCULARIZATION; REVIEW; SMOOTH MUSCLE FIBER;

ANIMALS; BODY PATTERNING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RESEARCH;

ARENA;

EID: 16244410511     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1080/10739680590895037     Document Type: Review

References (90)

1. Adams RH, Wilkinson GA, Weiss C, et al. (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13:295-306.
2. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. (1995). VEGF acts as a survival factor for newly-formed retinal vessels: implications for ROP. Nat Med 1:1024-1028.
3. Amaral SL, Linderman JR, Morse MM, Greene AS. (2001). Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8:57-67.
4. Anderson CR, Ponce AM, Price RJ. (2004). Absence of OX-43 antigen expression in invasive capillary sprouts: identification of a capillary sprout-specific endothelial phenotype. Am J Physiol Heart Circ Physiol 286:H346-H353.
5. Anderson CR, Ponce AM, Price RJ. (2004). Immuno-histochemical identification of an extracellular matrix scaffold that microguides capillary sprouting in vivo. J Histochem Cytochem 52:1063-1072.
6. Asahara T, Takahashi T, Masuda H, et al. (1999). VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18;3964-3972.
7. Baum O, Da Silva-Azevedo L, Willerding G, Wockel A, Planitzer G, Gossrau R, Pries AR, Zakrzewicz A. (2004). Endothelial nitric oxide synthase is the main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am J Physiol Heart Circ Physiol. Jul 1 [Epub ahead of print].
8. Benjamin LE, Hemo I, Keshet E. (1998). A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Dev Suppl 125:1591-1598.
9. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164.
10. Brown MD, Hudlicka O. (2003). Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6:1-14.
11. Brown MD, Walter H, Hansen-Smith FM, Hudlicka O, Egginton S. (1998). Lack of involvement of basic fibroblast growth factor (FGF-2) in capillary growth in skeletal muscles exposed to long-term contractile activity. Angiogenesis 2:81-91.
12. Buschmann I, Heil M, Jost M, Schaper W. (2003). Influence of inflammatory cytokines on arteriogenesis. Microcirculation 10:371-379.
13. Campbell AI, Zhao Y, Sandhu R, Stewart DJ. (2001). Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104:2242-2248.
14. Clark ER. (1918). Studies on growth of blood vessels in the tail of the frog larvae, by observation and experiment on the living animal. Am J Anat 23:37-88.
15. Clark ER, Clark EL. (1940). Microscopic observations on the extra-endothelial cells of living mammalian blood vessels. Am J Anat 66:1-49.
16. Cotter M, Hudlicka O, Vrbova G. (1973). Growth of capillaries during long-term activity in skeletal muscle. Bibl Anat 11:395-398.
17. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF. (2000). Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87:729-730.
18. Dobrian A, Wade SS, Prewitt RL. (1999). PDGF-A expression correlates with blood pressure and remodeling in 1K1C hypertensive rat arteries. Am J Physiol 276:H2159-H2167.
19. Folkman J. (2003). Fundamental concepts of the angiogenic process. Curr Mol Med 3:643-651.
20. Gale NW, Baluk P, Pan L, et al. (2001). Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230:151-160.
21. Gerritsen ME, Soriano R, Yang S, Ingle G, Zlot C, Toy K, Winer J, Draksharapu A, Peale F, Wu TD, Williams PM. (2002). In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. Physiol Genomics 10:13-20.
22. Giatromanolaki A, Sivridis E, Athanassou N, Zios E, Thorpe PE, Brekken RA, Gatter KC, Harris AL, Koukourakis IM, Koukourakis MI. (2001). The angiogenic pathway "vascular endothelial growth factor /flk 1 (KDR)-receptor" in rheumatoid arthritis and osteoarthritis. J Pathol 194:101-108.
23. Green AS. (2002). Application of physiological genomics to the microcirculation. Microcirculation 9:3-12.
24. Greene AS, Amaral SL. (2002). Microvascular angiogenesis and the renin - angiotensin system. Curr Hypertens Rep 4:56-62.
25. Gurunluoglu R, Lubiatowski P, Goldman CK, Carmevale K, Siemionow M. (2002). Enhancement of muscle flap hemodynamics by angiopoietin-1. Ann Plast Surg 48:401-409.
26. Hackett SE, Ozaki H, Strauss RW, Wahlin K, Suri C, Maisonpierre P, Yancopoulos G, Campochiaro PA. (2000). Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol 184:275-284.
27. Hansen-Smith F, Egginton S, Hudlicka O. (1998). Growth of arterioles in chronically stimulated adult rat skeletal muscle. Microcirculation 5:49-59.
28. Hautmann MB, Madsen CS, Owens GK. (1997). A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272:10948-10956.
29. Hebling PM, Saulnier DM, Brandli AW. (2000). The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. Dev Suppl 127:269-278.
30. Heil M, Ziegelhoeffer T, Wagner S, Fernandez B, Helisch A, Martin S, Tribulova S, Kuziel WA, Bachmann G, Schaper W. (2004). Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 94:671-677.
31. Helisch A, Schaper W. (2003). Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10:83-97.
32. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. (1999). Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Dev Suppl 126:3047-3055.
33. Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, Betsholtz C. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153:543-553.
34. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER. (2003). The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107:1359-1365.
35. Herzog Y, Kalcheim C, Kahane N, Reshef R, Neufeld G. (2001). Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 109:115-119.
36. Hirschi KK, Rohovsky SA, D'Amore PA. (1998). PDGF, TGF-b, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805-814.
37. Hirschi KK, Skalak TC, Peirce SM, Little CD. (2002). Vascular assembly in natural and engineered tissues. Ann NY Acad Sci 961:223-242.
38. Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK. (1992). Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res 71:1525-1532.
39. Hudlicka O, Tyler KR. (1986). Angiogenesis: The Growth of the Vascular System. London: Academic Press, 221.
40. Hudlicka O, Milkiewicz M, Cotter MA, Brown MD. (2002). Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles. Exp Physiol 87:373-381.
41. Hunter J. (1794). "Treatise on the Blood, Inflammation, and Gunshot Wounds." London.
42. Jain RK. (2003). Molecular regulation of vessel maturation. Nat Med 9:685-693.
43. Kamme F, Zhu J, Luo L, Yu J, Tran DT, Meurers B, Bittner A, Westlund K, Carlton S, Wan J. (2004). Single-cell laser-capture microdissection and RNA amplification. Methods Mol Med 99:215-223.
44. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685.
45. Lindahl P, Johansson BR, Leveen P, Betsholtz C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245.
46. Luttun A, Carmeliet P. (2004). Angiogenesis and lymphangiogenesis: highlights of the past year. Curr Opin Hematol 11:262-271.
47. Meyer J. (1853). Ann Charite (Berlin) 4:41-140.
48. Milkiewicz M, Brown MD, Egginton S, Hudlicka O. (2001). Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation 8:229-241.
49. Monos E, Lorant M, Feher E. (1997). Mechanisms of vascular adaptation to long-term orthostatic gravitational loading. J Gravita Physiol 4:P39-P40.
50. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J. (2003). Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 100:4736-4741.
51. Moyon D, Pardanaud L, Yuan L, Breant C, Eichmann A. (2001). Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128:3359-3370.
52. Murfee WL, Skalak TC, Peirce SM. (2004). Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype. Microcirculation (in press).
53. Myrhage R, Hudlicka O. (1978). Capillary growth in chronically stimulated adult skeletal muscle as studied by intravital microscopy and histological methods in rabbits and rats. Microvasc Res 16:73-90.
54. Nishiyama A, Dahlin KJ, Prince JT, Johnstone SR, Stallcup WB. (1991). The primary structure of NG2, a novel membrane-spanning proteoglycan. J Cell Biol 114:359-371.
55. Ozerdem U, Monosov E, Stallcup WB. (2002). NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc Res. 63:129-134.
56. Parker SB, Dobrian AD, Wade SS, Prewitt RL. (2000). AT(1) receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension. Am J Physiol Heart Circ Physiol 278:H613-H622.
57. Peale FV, Gerritsen ME. (2001). Gene profiling techniques and their application in angiogenesis and vascular development. J Pathol 195:7-19.
58. Peirce SM, Price RJ, Skalak TC. (2004). Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am J Physiol Heart Circ Physiol 286:H918-H925.
59. Peirce SM, Skalak TC. (2003). Microvascular remodeling: a complex continuum spanning angiogenesis to arteriogenesis. Microcirculation 10:99-111.
60. Peirce SM, Van Gieson EJ, Skalak TC. (2004). Multicellular simulation predicts microvascular patterning and in silico tissue assembly. FASEB J 18:731-733.
61. Price RJ, Owens GK, Skalak TC. (1994). Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation: evidence that capillary arterialization proceeds from terminal arterioles. Circ Res 75:520-527.
62. Price RJ, Skalak TC. (1996). Chronic alpha-1 adrenergic blockade stimulates terminal and arcade arteriolar growth in skeletal muscle. Am J Physiol 271:H752-H759.
63. Price RJ, Skalak TC. (1998). Prazosin administration enhances proliferation of arteriolar adventitial fibroblasts. Microvasc Res 55:138-145.
64. Price RJ, Less JR, Van Gieson EJ, Skalak TC. (2002). Hemodynamic stresses and structural remodeling of anastomosing arteriolar networks: design principles of collateral arteries. Microcirculation 9:111-124.
65. Pries AR, Reglin B, Secomb TW. (2001). Structural adaptation of microvascular networks: functional roles of adaptive responses. Am J Physiol Heart Circ Physiol 281:H1015-H1025.
66. Pries AR, Secomb TW, Gaehtgens P. (1995). Design principles of vascular beds. Circ Res 77:1017-1023.
67. Pries AR, Secomb TW, Gaehtgens P. (1998). Structural adaptation and stability of microvascular networks: theory and simulations. Am J Physiol 275:H349-H360.
68. Rezaee M, Penta K, Quetermous T. (2002). Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha(v)beta(3). Am J Physiol-Heart Circ Physiol 282:H1924-H1932.
69. Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA, Wagner PD. (1999). Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol 277:H2247-H2252.
70. Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Green AK, Corfas G, Folkman J. (2004). Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 10:255-261.
71. Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman J, Gimbrone MA Jr, Anderson DJ. (2001). Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230:139-150.
72. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. (2002). Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105:788-793.
73. Skalak TC, Price RJ. (1996). The role of mechanical stresses in microvascular remodeling. Microcirculation 3:143-165.
74. Stenmark KR, Bouchey D, Nemenoff R, Dempsey EC, Das M. (2000). Hypoxia-induced pulmonary vascular remodeling: contribution of the adventitial fibroblasts. Physisol Res 49:503-517.
75. Stupack DG, Cheresh DA. (2002). ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. Sci STKE 2000:PE7.
76. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
77. Thurston G, Baluk P, McDonald DM. (2000). Determinants of endothelial cell phenotype in venules. Microcirculation 7:67-80.
78. Van Gieson EJ, Murfee WL, Skalak TC, Price RJ. (2003). Enhanced smooth muscle cell coverage of microvessels exposed to increased hemodynamic stresses in vivo. Circ Res 92:929-936.
79. Van Royen N, Hoefer I, Buschmann I, Heil M, Kostin S, Deindl E, Vogel S, Korff T, Augustin H, Bode C, Piek JJ, Schaper W. (2002). Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J 16:432-434.
80. von Dassow G, Meir E, Munro EM, Odell GM. (2000). The segment polarity network is a robust developmental module. Nature 406:188-192.
81. Wagner PD. (2001). Skeletal muscle angiogenesis: a possible role for hypoxia. Adv Exp Med Biol 502:21-38.
82. Walsh DA, Pearson CI. (2001). Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res 3:147-153.
83. Whitesides GM. (2003). The 'right' size in nanobiotechnology. Nat Biotechnol 21:1161-1165.
84. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. (1998). Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514-18521.
85. Yamaguchi S, Yamaguchi M, Yatsuyanagi E, Yun SS, Nakajima N, Madri JA, Sumpio BE. (2002). Cyclic strain stimulates early growth response gene product 1-mediated expression of membrane type 1 matrix metalloproteinase in endothelium. Lab Invest 82:949-956.
86. Yancopoulos GD, Klagsbrun M, Folkman J. (1998). Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 93:661-664.
87. Zeller PJ, Skalak TC, Ponce AM, Price RJ. (2001). In vivo chemotactic properties and spatial expression of PDGF in developing mesenteric microvascular networks. Am J Physiol Heart Circ Physiol 280:H2116-H2125.
88. Zhang ZG, Zhang L, Tsang W, Soltanian-Zateh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M. (2002). Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 22:379-392.
89. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, Schaper W. (2004). Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94:230-238.
90. Zweifach BW. (1983). The microcirculation in experimental hypertension. State-of-the-art review. Hypertens 5:110-116.